All News

Drug Topics conducted an exclusive OTC survey for cough, cold and flu products.

Some believe it's not too late for community pharmacies to get into this field, which is growing by leaps and bounds.

At its 2008 midyear meeting, ASHP reemphasized its intent to push for the accreditatin of technician training programs and postgraduate training of residents.

Vaccines are not just for prevention, new ones are in development to treat diseases including malaria, HIV, and nicotine dependence.

Most Medicare providers and beneficiaries are unaware of the provision for comparative effectiveness research which is part of the Medicare Modernization Act. Politicians, policymakers, and manufacturers view it as a key initiative for the future of Medicare and beyond.

FDA is considering how to deal with the phaseout of chlorofluorocarbons from inhalers, which is only a year away.

Sapropterin approved for phenylketonuria treatment

New oral beta-blocker nebivolol approved by FDA

The Drug Topics time capsule was sealed the ASHP midyear meeting.

CMS announces accreditation deadlines for Part B DMEPOS suppliers

Two technology companies have joined together to integrate hospital IT systems.

SAMHSA: 3.1 million young adults have abused OTC cough medicine in their lifetime.

A new report urges sales reps to focus on pharmacy directors, P&T members, and chief medical officers when pitching new products.

Missouri is considering legislation that will let trained psychologists prescribe medications.

Rite Aid to exit Las Vegas market.

Impotent men can now take Cialis on a daily basis.

NACDS, 90 organizations send letter to state Medicaid directors on tamper-resistant Rxs.

Chronic disease patients are more compliant when Rx co-payments decrease.

AAHomecare supports Medicare anti-fraud measures.

CMS announces second round of Medicare DMEPOS competitive bidding program.

FDA warns seven pharmacies that the claims they have made for their bioidentical hormones are unsupported.

William Shields, named CEO of Artomick, a medication management and technology company.

FDA issues warning for bisphosphonates.

According to Consumers Union, drug prices rose at 75% of the Medicare Part D prescription drug plans.

The Centers for Medicare & Medicaid Services proposes a rule to reduce premiums for low-income subsidized patients.

Insulet, DexCom announce development agreement for glucose monitoring.

EMHS, PhRMA partner to improve access to medicine in eastern Maine.